OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway

Hongfa Wei,Wenchao Li,Leli Zeng,Ni Ding,Kuan Li,Hong Yu,Fei Jiang,Haofan Yin,Yu Xia,Cuncan Deng,Nan Cai,Xiancong Chen,Liang Gu,Huanjie Chen,Feiran Zhang,Yulong He,Jia Li,Changhua Zhang
DOI: https://doi.org/10.1186/s12943-024-02016-9
IF: 37.3
2024-06-08
Molecular Cancer
Abstract:Intestinal metaplasia (IM) is classified into complete intestinal metaplasia (CIM) and incomplete intestinal metaplasia (IIM). Patients diagnosed with IIM face an elevated susceptibility to the development of gastric cancer, underscoring the critical need for early screening measures. In addition to the complexities associated with diagnosis, the exact mechanisms driving the progression of gastric cancer in IIM patients remain poorly understood. OLFM4 is overexpressed in several types of tumors, including colorectal, gastric, pancreatic, and ovarian cancers, and its expression has been associated with tumor progression.
oncology,biochemistry & molecular biology
What problem does this paper attempt to address?